PAR Drugs and Chemicals Ltd has reported financial results for the period ended September 30, 2020.
Financial Results (H1 FY20-21)
The company has reported net sales of Rs.28.32 crores during the 6 months period ended September 30, 2020 as compared to Rs.26.83 crores during the period ended March 31, 2020.
The company has posted net profit of Rs.5.11 crores for the 6 months period ended September 30, 2020 as against Rs.3.17 crores for the 6 months period ended March 31, 2020.
The company has reported EPS of Rs.8.31 for the 6 months period ended September 30, 2020 as compared to Rs.5.16 for the 6 months period ended March 31, 2020.
|
| Total Income | ₹ 28.32 crs | ₹ 26.83 crs |  5.55% |
| Net Profit | ₹ 5.11 crs | ₹ 3.17 crs | 61.2% |
| EPS | ₹ 8.31 | ₹ 5.16 | 61.05% |
Financial Results (H1 FY20-21) - YoY Comparison
The company has reported net sales of Rs.28.32 crores during the 6 months period ended September 30, 2020 as compared to Rs.29.11 crores during the 6 months period ended September 30, 2019.
The company has posted net profit of Rs.5.11 crores for the 6 months period ended September 30, 2020 as against Rs.2.58 crores for the 6 months period ended September 30, 2019.
The company has reported EPS of Rs.8.31 for the 6 months period ended September 30, 2020 as compared to Rs.2.58 for the 6 months period ended September 30, 2019.
|
| Total Income | ₹ 28.32 crs | ₹ 29.11 crs | -2.71% |
| Net Profit | ₹ 5.11 crs | ₹ 2.58 crs | 98.06% |
| EPS | ₹ 8.31 | ₹ 2.58 | 222.09% |
|
